These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Isoprostanes: a putative key role in vascular diseases]. Cracowski JL Rev Med Interne; 2004 Jun; 25(6):459-63. PubMed ID: 15158317 [TBL] [Abstract][Full Text] [Related]
44. Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now? Ahmed OS; Galano JM; Pavlickova T; Revol-Cavalier J; Vigor C; Lee JC; Oger C; Durand T Essays Biochem; 2020 Sep; 64(3):463-484. PubMed ID: 32602531 [TBL] [Abstract][Full Text] [Related]
45. Isoprostanes: more than just mere markers. Crankshaw DJ; Rangachari PK Mol Cell Biochem; 2003 Nov; 253(1-2):125-30. PubMed ID: 14619962 [TBL] [Abstract][Full Text] [Related]
46. The generation and actions of isoprostanes. Roberts LJ; Morrow JD Biochim Biophys Acta; 1997 Apr; 1345(2):121-35. PubMed ID: 9106492 [No Abstract] [Full Text] [Related]
47. Isoprostanes - A novel major group of oxidative stress markers. Czerska M; Zieliński M; Gromadzińska J Int J Occup Med Environ Health; 2016; 29(2):179-90. PubMed ID: 26670350 [TBL] [Abstract][Full Text] [Related]
48. [The role of isoprostanes and oxidative stress in pathology of circulatory system]. Mika P; Gross I; Koza M; Soja J; Nagraba K; Gielicz A; Sładek K Pol Arch Med Wewn; 2003 Mar; 109(3):299-303. PubMed ID: 12924178 [No Abstract] [Full Text] [Related]
49. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. Lawson JA; Rokach J; FitzGerald GA J Biol Chem; 1999 Aug; 274(35):24441-4. PubMed ID: 10455102 [No Abstract] [Full Text] [Related]
50. The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Cracowski JL Heart; 2003 Aug; 89(8):821-2. PubMed ID: 12860842 [No Abstract] [Full Text] [Related]
51. [The role of iso-prostanes and oxidative stress in the pathology of respiratory system]. Mika P; Gross I; Koza M; Soja J; Nagraba K; Gielicz A; Sładek K Pol Arch Med Wewn; 2002 Nov; 108(5):1103-9. PubMed ID: 12685253 [No Abstract] [Full Text] [Related]
52. Reactive oxygen species in the normal and acutely injured liver. Jaeschke H; Ramachandran A J Hepatol; 2011 Jul; 55(1):227-8. PubMed ID: 21238521 [No Abstract] [Full Text] [Related]
53. Microvascular dysfunction following cardiopulmonary bypass plays a central role in postoperative organ dysfunction. Kant S; Banerjee D; Sabe SA; Sellke F; Feng J Front Med (Lausanne); 2023; 10():1110532. PubMed ID: 36865056 [TBL] [Abstract][Full Text] [Related]
54. An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers. Santos-Gomes J; Gandra I; Adão R; Perros F; Brás-Silva C Front Cardiovasc Med; 2022; 9():924873. PubMed ID: 35911521 [TBL] [Abstract][Full Text] [Related]
55. The Role of Urine F2-ISOPROSTANE CONcentration in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Haemorrhage-A Poor Prognostic Factor. Wiśniewski K; Popęda M; Tomasik B; Bieńkowski M; Bobeff EJ; Stefańczyk L; Tybor K; Hupało M; Jaskólski DJ Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375060 [No Abstract] [Full Text] [Related]